Saturday, January 09, 2021 2:31:32 AM
Manufacturing and Supplying Adaptogens
MINDCURE seeks to commercialize the therapeutic potential of nootropics, psychoactive products, and psychedelic substances that promote productivity and enhance mental health.
The first line of products that MINDCURE intends to launch are three types of organic mushroom nootropics. These products will be distributed under the following product names: MINDCURE Lion’s Mane Focus, MINDCURE Reishi Energy, and MINDCURE Turkey Tail Immunity. Each of these products will be available in powdered and capsule form.
MINDCURE is evaluating the legal and commercial viability of psychedelic compounds, such as psilocybin, as part of its future product candidates.
The process will comply with regulatory certifications and licensing within Canadian federal regulatory agencies (including Health Canada) and the US Federal regulatory agencies (including the FDA).
https://mindcure.com/our-focus/
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM